Biological Plasticity, Cell Danger Signaling & Symptom Management: Where To Draw the Line?

There’s a fine balance between treatment and non-treatment. Philosophically I verge more on the side of conservative and “less is more treatment” for many reasons. My current philosophy in these regards is based upon the potential adverse effects of pharmaceuticals, and of the assault I believe many drugs have on memory-based physiological processes, also known